Back

RAGE mediates LPS-induced inflammatory pain in human skin

2025-12-19 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

Inflammatory pain is a major clinical challenge, yet appropriate human models mimicking local infection are lacking. We established a novel human pain model based on intradermal administration of lipopolysaccharide (LPS), a component of Gram-negative bacteria, and investigated the time course and underlying molecular mechanisms of inflammatory pain hypersensitivity. In a placebo-controlled pilot study with 12 healthy subjects, the intradermal LPS injection induced hyperaemia peaking at 4.5 h and...

Predicted journal destinations